US 7998968
Substituted pyrimidines and [1,2, 4] triazoles and the use thereof for treating prophylaxis, cardiovascular diseases, metabolic diseases and/or central nervous system diseases
granted A61PA61P25/00A61P3/00
Quick answer
US patent 7998968 (Substituted pyrimidines and [1,2, 4] triazoles and the use thereof for treating prophylaxis, cardiovascular diseases, metabolic diseases and/or central nervous system diseases) held by Takeda Pharmaceutical Company Limited expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 38
- CPC classes
- A61P, A61P25/00, A61P3/00, A61P9/00, A61P9/10